Literature DB >> 32778610

Regulatory T Cells Contribute to Resistance against Lyme Arthritis.

Emily M Siebers1, Elizabeth S Liedhegner1, Michael W Lawlor2,3, Ronald F Schell4,5,6,7, Dean T Nardelli8.   

Abstract

The symptoms of Lyme disease are caused by inflammation induced by species of the Borrelia burgdorferi sensu lato complex. The various presentations of Lyme disease in the population suggest that differences exist in the intensity and regulation of the host response to the spirochete. Previous work has described correlations between the presence of regulatory T cells and recovery from Lyme arthritis. However, the effects of Foxp3-expressing CD4+ T cells existing prior to, and during, B. burgdorferi infection have not been well characterized. Here, we used C57BL/6 "depletion of regulatory T cell" mice to assess the effects these cells have on the arthritis-resistant phenotype characteristic of this mouse strain. We showed that depletion of regulatory T cells prior to infection with B. burgdorferi resulted in sustained swelling, as well as histopathological changes, of the tibiotarsal joints that were not observed in infected control mice. Additionally, in vitro stimulation of splenocytes from these regulatory T cell-depleted mice resulted in increases in gamma interferon and interleukin-17 production and decreases in interleukin-10 production that were not evident among splenocytes of infected mice in which Treg cells were not depleted. Depletion of regulatory T cells at various times after infection also induced rapid joint swelling. Collectively, these findings provide evidence that regulatory T cells existing at the time of, and possibly after, B. burgdorferi infection may play an important role in limiting the development of arthritis.
Copyright © 2020 American Society for Microbiology.

Entities:  

Keywords:  Borrelia burgdorferizzm321990; Lyme arthritis; Lyme disease; Treg cells; arthritis; inflammation

Mesh:

Year:  2020        PMID: 32778610      PMCID: PMC7573436          DOI: 10.1128/IAI.00160-20

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  48 in total

1.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.

Authors:  Estelle Bettelli; Yijun Carrier; Wenda Gao; Thomas Korn; Terry B Strom; Mohamed Oukka; Howard L Weiner; Vijay K Kuchroo
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

2.  CD4(+) FoxP3(+) regulatory T cells suppress fatal T helper 2 cell immunity during pulmonary fungal infection.

Authors:  Bianca Schulze; Daniel Piehler; Maria Eschke; Heiner von Buttlar; Gabriele Köhler; Tim Sparwasser; Gottfried Alber
Journal:  Eur J Immunol       Date:  2014-10-29       Impact factor: 5.532

3.  T cell cytokine pattern in the joints of patients with Lyme arthritis and its regulation by cytokines and anticytokines.

Authors:  Z Yin; J Braun; L Neure; P Wu; U Eggens; A Krause; T Kamradt; J Sieper
Journal:  Arthritis Rheum       Date:  1997-01

4.  Early induction of gamma interferon and interleukin-10 production in draining lymph nodes from mice infected with Borrelia burgdorferi.

Authors:  F Ganapamo; V A Dennis; M T Philipp
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

5.  The β₃-integrin ligand of Borrelia burgdorferi is critical for infection of mice but not ticks.

Authors:  Laura C Ristow; Halli E Miller; Lavinia J Padmore; Rekha Chettri; Nita Salzman; Melissa J Caimano; Patricia A Rosa; Jenifer Coburn
Journal:  Mol Microbiol       Date:  2012-07-18       Impact factor: 3.501

6.  Foxp3+ CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion.

Authors:  Santiago Zelenay; Thiago Lopes-Carvalho; Iris Caramalho; Maria Francisca Moraes-Fontes; Manuel Rebelo; Jocelyne Demengeot
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-07       Impact factor: 11.205

7.  Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease.

Authors:  Gary P Wormser; Dustin Brisson; Dionysios Liveris; Klára Hanincová; Sabina Sandigursky; John Nowakowski; Robert B Nadelman; Sara Ludin; Ira Schwartz
Journal:  J Infect Dis       Date:  2008-11-01       Impact factor: 5.226

8.  Inhibition of interleukin-17 prevents the development of arthritis in vaccinated mice challenged with Borrelia burgdorferi.

Authors:  Matthew A Burchill; Dean T Nardelli; Douglas M England; David J DeCoster; John A Christopherson; Steven M Callister; Ronald F Schell
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

9.  CD4+ cell-derived interleukin-17 in a model of dysregulated, Borrelia-induced arthritis.

Authors:  Emily S Hansen; Megan E Johnson; Ronald F Schell; Dean T Nardelli
Journal:  Pathog Dis       Date:  2016-08-21       Impact factor: 3.166

10.  Limitations of Foxp3(+) Treg depletion following viral infection in DEREG mice.

Authors:  Allison F Christiaansen; Paola M Boggiatto; Steven M Varga
Journal:  J Immunol Methods       Date:  2014-03-15       Impact factor: 2.303

View more
  2 in total

1.  Predicting Lyme Disease From Patients' Peripheral Blood Mononuclear Cells Profiled With RNA-Sequencing.

Authors:  Daniel J B Clarke; Alison W Rebman; Allison Bailey; Megan L Wojciechowicz; Sherry L Jenkins; John E Evangelista; Matteo Danieletto; Jinshui Fan; Mark W Eshoo; Michael R Mosel; William Robinson; Nitya Ramadoss; Jason Bobe; Mark J Soloski; John N Aucott; Avi Ma'ayan
Journal:  Front Immunol       Date:  2021-03-08       Impact factor: 7.561

Review 2.  Lyme arthritis: linking infection, inflammation and autoimmunity.

Authors:  Robert B Lochhead; Klemen Strle; Sheila L Arvikar; Janis J Weis; Allen C Steere
Journal:  Nat Rev Rheumatol       Date:  2021-07-05       Impact factor: 32.286

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.